Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Follow-on Biologics Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Recombinant Non-glycosylated Proteins
  • 1.3.3 Recombinant Glycosylated Proteins
  • 1.3.4 Recombinant Peptides
• 1.4 Market Segment by Application
  • 1.4.1 Global Follow-on Biologics Market Share by Application (2019-2025)
  • 1.4.2 Oncology
  • 1.4.3 Blood Disorders
  • 1.4.4 Chronic Diseases
  • 1.4.5 Autoimmune Diseases
  • 1.4.6 Growth Hormone Deficiency
  • 1.4.7 Infectious Diseases
  • 1.4.8 Other Diseases
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Follow-on Biologics Market Size
  • 2.1.1 Global Follow-on Biologics Revenue 2014-2025
  • 2.1.2 Global Follow-on Biologics Sales 2014-2025
• 2.2 Follow-on Biologics Growth Rate by Regions
  • 2.2.1 Global Follow-on Biologics Sales by Regions 2014-2019
  • 2.2.2 Global Follow-on Biologics Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Follow-on Biologics Sales by Manufacturers
  • 3.1.1 Follow-on Biologics Sales by Manufacturers 2014-2019
  • 3.1.2 Follow-on Biologics Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Follow-on Biologics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Follow-on Biologics Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Follow-on Biologics Market Concentration Ratio (CR5 and HHI)
• 3.3 Follow-on Biologics Price by Manufacturers
• 3.4 Key Manufacturers Follow-on Biologics Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Follow-on Biologics Market
• 3.6 Key Manufacturers Follow-on Biologics Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Recombinant Non-glycosylated Proteins Sales and Revenue (2014-2019)
  • 4.1.2 Recombinant Glycosylated Proteins Sales and Revenue (2014-2019)
  • 4.1.3 Recombinant Peptides Sales and Revenue (2014-2019)
• 4.2 Global Follow-on Biologics Sales Market Share by Type
• 4.3 Global Follow-on Biologics Revenue Market Share by Type
• 4.4 Follow-on Biologics Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Follow-on Biologics Sales by Application

6 United States

• 6.1 United States Follow-on Biologics Breakdown Data by Company
• 6.2 United States Follow-on Biologics Breakdown Data by Type
• 6.3 United States Follow-on Biologics Breakdown Data by Application

7 European Union

• 7.1 European Union Follow-on Biologics Breakdown Data by Company
• 7.2 European Union Follow-on Biologics Breakdown Data by Type
• 7.3 European Union Follow-on Biologics Breakdown Data by Application

8 China

• 8.1 China Follow-on Biologics Breakdown Data by Company
• 8.2 China Follow-on Biologics Breakdown Data by Type
• 8.3 China Follow-on Biologics Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Follow-on Biologics Breakdown Data by Company
• 9.2 Rest of World Follow-on Biologics Breakdown Data by Type
• 9.3 Rest of World Follow-on Biologics Breakdown Data by Application
• 9.4 Rest of World Follow-on Biologics Breakdown Data by Countries
  • 9.4.1 Rest of World Follow-on Biologics Sales by Countries
  • 9.4.2 Rest of World Follow-on Biologics Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Sandoz
  • 10.1.1 Sandoz Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Follow-on Biologics
  • 10.1.4 Follow-on Biologics Product Introduction
  • 10.1.5 Sandoz Recent Development
• 10.2 Pfizer
  • 10.2.1 Pfizer Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Follow-on Biologics
  • 10.2.4 Follow-on Biologics Product Introduction
  • 10.2.5 Pfizer Recent Development
• 10.3 Teva Pahrmaceutical
  • 10.3.1 Teva Pahrmaceutical Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Follow-on Biologics
  • 10.3.4 Follow-on Biologics Product Introduction
  • 10.3.5 Teva Pahrmaceutical Recent Development
• 10.4 Celltrion
  • 10.4.1 Celltrion Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Follow-on Biologics
  • 10.4.4 Follow-on Biologics Product Introduction
  • 10.4.5 Celltrion Recent Development
• 10.5 Biocon
  • 10.5.1 Biocon Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Follow-on Biologics
  • 10.5.4 Follow-on Biologics Product Introduction
  • 10.5.5 Biocon Recent Development
• 10.6 Amgen
  • 10.6.1 Amgen Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Follow-on Biologics
  • 10.6.4 Follow-on Biologics Product Introduction
  • 10.6.5 Amgen Recent Development
• 10.7 Samsung Biologics
  • 10.7.1 Samsung Biologics Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Follow-on Biologics
  • 10.7.4 Follow-on Biologics Product Introduction
  • 10.7.5 Samsung Biologics Recent Development
• 10.8 Mylan
  • 10.8.1 Mylan Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Follow-on Biologics
  • 10.8.4 Follow-on Biologics Product Introduction
  • 10.8.5 Mylan Recent Development
• 10.9 Dr. Reddy's Laboratories
  • 10.9.1 Dr. Reddy's Laboratories Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Follow-on Biologics
  • 10.9.4 Follow-on Biologics Product Introduction
  • 10.9.5 Dr. Reddy's Laboratories Recent Development
• 10.10 Stada Arzneimittel AG
  • 10.10.1 Stada Arzneimittel AG Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Follow-on Biologics
  • 10.10.4 Follow-on Biologics Product Introduction
  • 10.10.5 Stada Arzneimittel AG Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Follow-on Biologics Sales Channels
  • 11.2.2 Follow-on Biologics Distributors
• 11.3 Follow-on Biologics Customers

12 Market Forecast

• 12.1 Global Follow-on Biologics Sales and Revenue Forecast 2019-2025
• 12.2 Global Follow-on Biologics Sales Forecast by Type
• 12.3 Global Follow-on Biologics Sales Forecast by Application
• 12.4 Follow-on Biologics Forecast by Regions
  • 12.4.1 Global Follow-on Biologics Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Follow-on Biologics Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Follow-on Biologics is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Follow-on Biologics.

This report studies the global market size of Follow-on Biologics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Follow-on Biologics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Sandoz
Pfizer
Teva Pahrmaceutical
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy's Laboratories
Stada Arzneimittel AG

Market Segment by Product Type
Recombinant Non-glycosylated Proteins
Recombinant Glycosylated Proteins
Recombinant Peptides

Market Segment by Application
Oncology
Blood Disorders
Chronic Diseases
Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Other Diseases

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Follow-on Biologics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Follow-on Biologics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Follow-on Biologics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025